Intravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: A preliminary multifocal-ERG and OCT study

Documenta Ophthalmologica

Volumn 114, Issue 1, 2007, Pages 37-44

  Moschos, Marilita M ^a,b   Brouzas, Dimitrios ^a   Apostolopoulos, Michael ^a   Koutsandrea, Chrysanthi ^a   Loukianou, Eleni ^a   Moschos, Michael ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Age related macular degeneration (ARMD); Bevacizumab (Avastin); Choroidal neovascularization (CNV); Multifocal Electroretinogram (MFERG); Optical Coherence Tomography (OCT)

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; ELECTRORETINOGRAM; ELECTRORETINOGRAPHY; EYE DISEASE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; MULTIFOCAL ELECTRORETINOGRAM; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; SIDE EFFECT; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; SYSTEMIC DISEASE; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; ELECTRORETINOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VITREOUS BODY;

EID: 33846820301     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-006-9036-7     Document Type: Article

References (16)

1. Kroll P, Meyer CH (2006) Which treatment is best for which AMD patients. Br J Ophthalmol 90:128-130
2. Chang TS, Freund KB, de la Cruz Z, Yannuzi LA, Green WR (1994) Clinicopathological correlation of choroidal neovascularisation demonstrated by indocyanine green angiography in a patient with retention of good vision for almost four years. Retina 14:114-124
3. Green WR, Wilson DJ (1986) Choroidal neovascularisation. Ophthalmology 93:1169-1176
4. Green WR, Enger C (1993) Age related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 100:1519-1535
5. Macular Photocoagulation Study Group. (1991) Subfoveal neovascular lesions in age related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 109:1242-1257
6. Verteporfin in photodynamic therapy Study Group (2001) Vertyeporfin therapy of subfoveal choroidal neovascularisation in age related macular degeneration: Two years results of randomized clinical trials including lesions with occult or classic choroidal neovasularisation-verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131:541-560
7. TAP Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularisation in age related macular degeneration with Verteporfin: two years results of 2 randomized clinical trials-TAP Report 2. Arch Ophthalmol 119:198-207
8. Gragoudas ES, Adamis AP, Cunningham ET et al (2004) Pegaptanid for neovasular age related macular degeneration. N Engl J Med 351:2805-2816
9. Spaide R (2006) New treatments for AMD. Ophthalmology 113:160-161
10. Ferrara N, Hillan KJ, Gerber HP, Novotny W (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391-400
11. Sutter EE, Tran D (1992) The field topography of ERG in man, 1. The photopic luminance response. Vision Res 32:433-466
12. Michels S, Rosenfeld PJ, Puliafito CA et al (2005) Systemic bevacizumab (Avastin) therapy for neo-vascular age related macular degeneration: twelve-week results of an uncontrolled open-label study. Ophthalmology 112:1035-1074
13. Rosenfeld PJ, Moshfeghi AA, Puliafito CA et al (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age related macular degeneration. Ophthalmic Surg Lasers Imaging 36:270-271
14. Spaide FR, Laud K, Fine HF et al (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age related macular degeneration. Retina 26:383-390
15. Feigl B, Brown B, Lovie-Kitchin J, Lee L (2005) Dynamics of retinal function after multiple photodynamic therapies in age related macular degeneration. Doc Ophthalmologica 111:135-148
16. Moschos M, Panayotidis D, Theodossiadis G, Moschos MM (2004) Assessment of macular function by electroretinography in age-related macular degeneration before and after photodynamic therapy. J Fr Ophtalmologie 27:1001-1006